186 related articles for article (PubMed ID: 22194042)
21. Some lessons from the tissue transglutaminase knockout mouse.
Sarang Z; Tóth B; Balajthy Z; Köröskényi K; Garabuczi E; Fésüs L; Szondy Z
Amino Acids; 2009 Apr; 36(4):625-31. PubMed ID: 18584284
[TBL] [Abstract][Full Text] [Related]
22. Tissue transglutaminase (TG2) protects cardiomyocytes against ischemia/reperfusion injury by regulating ATP synthesis.
Szondy Z; Mastroberardino PG; Váradi J; Farrace MG; Nagy N; Bak I; Viti I; Wieckowski MR; Melino G; Rizzuto R; Tósaki A; Fesus L; Piacentini M
Cell Death Differ; 2006 Oct; 13(10):1827-9. PubMed ID: 16528383
[No Abstract] [Full Text] [Related]
23. Transglutaminase 2 null macrophages respond to lipopolysaccharide stimulation by elevated proinflammatory cytokine production due to an enhanced αvβ3 integrin-induced Src tyrosine kinase signaling.
Sarang Z; Köröskényi K; Pallai A; Duró E; Melino G; Griffin M; Fésüs L; Szondy Z
Immunol Lett; 2011 Jul; 138(1):71-8. PubMed ID: 21420434
[TBL] [Abstract][Full Text] [Related]
24. Detection and identification of potential transglutaminase 2 substrates in the mouse renal glomeruli.
Ito Y; Tatsukawa H; Yamaguchi H; Takahashi K; Hitomi K; Yuzawa Y
Arch Biochem Biophys; 2018 Dec; 660():11-19. PubMed ID: 30300608
[TBL] [Abstract][Full Text] [Related]
25. Transglutaminase type II is a key element in the regulation of the anti-inflammatory response elicited by apoptotic cell engulfment.
Falasca L; Iadevaia V; Ciccosanti F; Melino G; Serafino A; Piacentini M
J Immunol; 2005 Jun; 174(11):7330-40. PubMed ID: 15905580
[TBL] [Abstract][Full Text] [Related]
26. Non-alcoholic fatty liver disease severity is modulated by transglutaminase type 2.
Piacentini M; Baiocchini A; Del Nonno F; Melino G; Barlev NA; Rossin F; D'Eletto M; Falasca L
Cell Death Dis; 2018 Feb; 9(3):257. PubMed ID: 29449533
[TBL] [Abstract][Full Text] [Related]
27. Vena cava and aortic smooth muscle cells express transglutaminases 1 and 4 in addition to transglutaminase 2.
Johnson KB; Petersen-Jones H; Thompson JM; Hitomi K; Itoh M; Bakker EN; Johnson GV; Colak G; Watts SW
Am J Physiol Heart Circ Physiol; 2012 Apr; 302(7):H1355-66. PubMed ID: 22307675
[TBL] [Abstract][Full Text] [Related]
28. The functional relationship between transglutaminase 2 and transforming growth factor β1 in the regulation of angiogenesis and endothelial-mesenchymal transition.
Wang Z; Perez M; Lee ES; Kojima S; Griffin M
Cell Death Dis; 2017 Sep; 8(9):e3032. PubMed ID: 28880274
[TBL] [Abstract][Full Text] [Related]
29. Transglutaminase-2 differently regulates cartilage destruction and osteophyte formation in a surgical model of osteoarthritis.
Orlandi A; Oliva F; Taurisano G; Candi E; Di Lascio A; Melino G; Spagnoli LG; Tarantino U
Amino Acids; 2009 Apr; 36(4):755-63. PubMed ID: 18584285
[TBL] [Abstract][Full Text] [Related]
30. Tissue transglutaminase contributes to interstitial renal fibrosis by favoring accumulation of fibrillar collagen through TGF-beta activation and cell infiltration.
Shweke N; Boulos N; Jouanneau C; Vandermeersch S; Melino G; Dussaule JC; Chatziantoniou C; Ronco P; Boffa JJ
Am J Pathol; 2008 Sep; 173(3):631-42. PubMed ID: 18688035
[TBL] [Abstract][Full Text] [Related]
31. Biological functionalities of transglutaminase 2 and the possibility of its compensation by other members of the transglutaminase family.
Odii BO; Coussons P
ScientificWorldJournal; 2014; 2014():714561. PubMed ID: 24778599
[TBL] [Abstract][Full Text] [Related]
32. Reactivity of the N-terminal region of fibronectin protein to transglutaminase 2 and factor XIIIA.
Hoffmann BR; Annis DS; Mosher DF
J Biol Chem; 2011 Sep; 286(37):32220-30. PubMed ID: 21757696
[TBL] [Abstract][Full Text] [Related]
33. Extracellular transglutaminase 2 induces myotube hypertrophy through G protein-coupled receptor 56.
Kitakaze T; Yoshikawa M; Kobayashi Y; Kimura N; Goshima N; Ishikawa T; Ogata Y; Yamashita Y; Ashida H; Harada N; Yamaji R
Biochim Biophys Acta Mol Cell Res; 2020 Feb; 1867(2):118563. PubMed ID: 31666191
[TBL] [Abstract][Full Text] [Related]
34. TG2 transamidating activity acts as a reostat controlling the interplay between apoptosis and autophagy.
Rossin F; D'Eletto M; Macdonald D; Farrace MG; Piacentini M
Amino Acids; 2012 May; 42(5):1793-802. PubMed ID: 21479826
[TBL] [Abstract][Full Text] [Related]
35. Transglutaminase inhibitors attenuate vascular calcification in a preclinical model.
Beazley KE; Banyard D; Lima F; Deasey SC; Nurminsky DI; Konoplyannikov M; Nurminskaya MV
Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):43-51. PubMed ID: 23117658
[TBL] [Abstract][Full Text] [Related]
36. Infection-driven activation of transglutaminase 2 boosts glucose uptake and hexosamine biosynthesis in epithelial cells.
Maffei B; Laverrière M; Wu Y; Triboulet S; Perrinet S; Duchateau M; Matondo M; Hollis RL; Gourley C; Rupp J; Keillor JW; Subtil A
EMBO J; 2020 Apr; 39(8):e102166. PubMed ID: 32134139
[TBL] [Abstract][Full Text] [Related]
37. Transglutaminase 2 regulates osteoclast differentiation via a Blimp1-dependent pathway.
Kim WS; Kim H; Jeong EM; Kim HJ; Lee ZH; Kim IG; Kim HH
Sci Rep; 2017 Sep; 7(1):10626. PubMed ID: 28878266
[TBL] [Abstract][Full Text] [Related]
38. Transglutaminase activity arising from Factor XIIIA is required for stabilization and conversion of plasma fibronectin into matrix in osteoblast cultures.
Cui C; Wang S; Myneni VD; Hitomi K; Kaartinen MT
Bone; 2014 Feb; 59():127-38. PubMed ID: 24246248
[TBL] [Abstract][Full Text] [Related]
39. Tissue Transglutaminase contributes to experimental multiple sclerosis pathogenesis and clinical outcome by promoting macrophage migration.
van Strien ME; de Vries HE; Chrobok NL; Bol JGJM; Breve JJP; van der Pol SMP; Kooij G; van Buul JD; Karpuj M; Steinman L; Wilhelmus MM; Sestito C; Drukarch B; Van Dam AM
Brain Behav Immun; 2015 Nov; 50():141-154. PubMed ID: 26133787
[TBL] [Abstract][Full Text] [Related]
40. Transglutaminase 2 regulates mallory body inclusion formation and injury-associated liver enlargement.
Strnad P; Harada M; Siegel M; Terkeltaub RA; Graham RM; Khosla C; Omary MB
Gastroenterology; 2007 Apr; 132(4):1515-26. PubMed ID: 17408647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
